NAG Inhibitors refer to a specialized category of chemical compounds designed to target and modulate the activity of N-acetylglucosamine (NAG), a molecule that plays a crucial role in various biological processes, particularly in the context of carbohydrate metabolism and the synthesis of complex glycoconjugates. NAG is an amino sugar found in glucose and is commonly found as a component of various macromolecules, including glycoproteins, glycolipids, and proteoglycans. Inhibitors of NAG are developed to interact with this specific molecule, influencing its role in cellular processes where NAG is involved.
Structurally, NAG inhibitors are designed to engage with NAG molecules, disrupting their normal functioning or metabolism within the cell. NAG is involved in the synthesis of chitin, a structural polysaccharide found in the cell walls of fungi and the exoskeletons of arthropods. In addition, NAG is a component of the glycosaminoglycans (GAGs) found in the extracellular matrix and proteoglycans, which are essential for cell adhesion, signaling, and tissue development. By targeting NAG, these inhibitors may impact various cellular processes and pathways, making them valuable tools for researchers studying carbohydrate metabolism, chitin synthesis, glycosylation, and extracellular matrix biology. Understanding the modulation of NAG by inhibitors can provide insights into the roles of NAG in diverse biological contexts, contributing to our knowledge of fundamental cellular processes and applications in fields ranging from biochemistry to structural biology.
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
(Z)-Pugnac | 132489-69-1 | sc-204415A sc-204415 | 5 mg 10 mg | $220.00 $373.00 | 3 | |
Known inhibitor of O-GlcNAcase, preventing the removal of NAG from proteins. | ||||||
Thiamet G | 1009816-48-1 | sc-224307 sc-224307A | 1 mg 5 mg | $51.00 $94.00 | 1 | |
Another inhibitor of O-GlcNAcase. | ||||||
Alloxan monohydrate | 2244-11-3 | sc-254940 | 10 g | $53.00 | ||
Impacts glucosamine synthesis, which can indirectly affect NAG levels. | ||||||
6-Diazo-5-oxo-L-norleucine | 157-03-9 | sc-227078 sc-227078A sc-227078B sc-227078C | 5 mg 25 mg 100 mg 250 mg | $82.00 $285.00 $908.00 $2152.00 | ||
Inhibits glutamine-fructose-6-phosphate transaminase, affecting glucosamine and NAG synthesis. | ||||||
Acetazolamide | 59-66-5 | sc-214461 sc-214461A sc-214461B sc-214461C sc-214461D sc-214461E sc-214461F | 10 g 25 g 100 g 250 g 500 g 1 kg 2 kg | $79.00 $174.00 $425.00 $530.00 $866.00 $1450.00 $2200.00 | 1 | |
While primarily a carbonic anhydrase inhibitor, it may influence glucosamine-6-phosphate isomerase. | ||||||
Azaserine | 115-02-6 | sc-29063 sc-29063A | 50 mg 250 mg | $306.00 $906.00 | 15 | |
Inhibits glutamine-fructose-6-phosphate transaminase. | ||||||
Streptozotocin (U-9889) | 18883-66-4 | sc-200719 sc-200719A | 1 g 5 g | $110.00 $510.00 | 152 | |
Affects the hexosamine biosynthesis pathway, potentially influencing NAG. | ||||||
Swainsonine | 72741-87-8 | sc-201362 sc-201362C sc-201362A sc-201362D sc-201362B | 1 mg 2 mg 5 mg 10 mg 25 mg | $135.00 $246.00 $619.00 $799.00 $1796.00 | 6 | |
Inhibits alpha-mannosidase, potentially affecting N-linked glycosylation pathways involving NAG. | ||||||